Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.
Researchers use controls to help them understand what effect a
new therapy or drug might have on a particular condition.
Clinical research practice favors placebo controls over
usual-care controls. Sometimes a person can have a response,
positive or negative, to the placebo control. These responses are
known as the "placebo effect and nocebo effect”. The placebo effect
demonstrates how positive thinking can improve treatment outcomes.
Likewise, the nocebo effect suggests that negative thinking may
have the opposite effect. But is this information impacting
reported outcomes?
In this episode, Dr. Dominique Demolle, Chief Executive
Officer of Cognivia will discuss the implications of the placebo
and nocebo effect on clinical development and ways to understand
the impact these effects have on the results of clinical
trials.
About the Podcast
Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.